SNS Flashcards
Name SNS agonists
Phenylephrine/oxymetazoline Alpha methyldopa/clonidine Dopamine/Dobutamine Salbutamol/Salmetarol Amphetamine Ephedrine Cocaine Adrenaline
MOA of phenylephrine
Selective a1 adrenergic receptor agonist
MOA of a-methyldopa
a2-adrenergic agonist
MOA of dopamine
B1-adrenergic agonist
MOA of salbutamol
B2-adrenergic agonist
Difference between amphetamine and ephedrine
Amphetamine has a potent release, whereas ephedrine has a weak release
MOA of amphetamine
Increases synaptic adrenaline, noradrenaline, dopamine and seratonin through re-uptake inhibition
MOA of ephedrine
Increases synaptic adrenaline, noradrenaline, dopamine and seratonin through re-uptake inhibition
MOA of cocaine
dopamine and noradrenaline re-uptake inhibitor
MOA of adrenaline
Bind to adrenergic receptors
Use of phenylephrine
Red eye allergy
Nasal congestion
Use of a-methyldopa
Hypertension
Use of dopamine
Acute heart failure/cardiogenic shock
Renal failure
Use of salbutamol
asthma
COPD
Premature labour
Use of amphetamine
ADHD
Narcolepsy
Reduce fatigue and appetite
Use of cocaine
Increases alertness, feelings of well-being and euphoria, energy and motor activity, feelings of competence and sexuality
Use of adrenaline
Anaphylaxis
Acute heart failure
Ventricular fibrillation
Cause vasodilation for local anaesthetic
Side effects of phenylephrine
Hypertension
Prostatic hyperplasia
Side effects of a-methyldopa
Depression Apathy Anxiety Fatigue Reduced awareness and cognition
Side effects of dopamine
Hypertension
Angina
Arrhythmia
Tachycardia